Flash | Citi Friday Charts: The Curious Case of GLP-1 Copycats CITI'S TAKE This week's Citi Friday Charts assess the size of Brazil's compounded GLP-1 market using SECEX data on semaglutide and tirzepatide API imports, the key ingredients used in compounded pens. Beyond the sharp acceleration in API imports since 2024 (Chart #1), the data highlights a changing import mix following ANVISA's prohibition of semaglutide compounding from Aug-2025, cementing tirzepatide as the dominant peptide in the segment. Cha ...